Statement of Principles concerning Guillain-Barre syndrome No. 59 of 2013

Administered by Department of Veterans' Affairs

Legislation au F2013L01647 Not in force Legislative Instrument

Legislation content

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 59 of 2013

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY NOTES FOR TABLING

 

 

  1. The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), revokes Instrument No. 53 of 2005, determined under subsection 196B(2) of the VEA concerning Guillain-Barre syndrome.

 

2.             The Authority is of the view that there is sound medical-scientific evidence that indicates that Guillain-Barre syndrome and death from Guillain-Barre syndrome can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(2) of the VEA a Statement of Principles, Instrument No. 59 of 2013 concerning Guillain-Barre syndrome.  This Instrument will in effect replace the revoked Statement of Principles.

 

3.             The provisions of the Military Rehabilitation and Compensation Act 2004 (the MRCA) relating to claims for compensation commenced on 1 July 2004.  Claims under section 319 of the MRCA for acceptance of liability for a service injury sustained, a service disease contracted or service death on or after 1 July 2004 are determined by the Military Rehabilitation and Compensation Commission by reference to Statements of Principles issued by the Authority pursuant to the VEA.

 

4.             The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

 

before it can be said that a reasonable hypothesis has been raised connecting Guillain-Barre syndrome or death from Guillain-Barre syndrome, with the circumstances of that service.

 

5.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 18 May 2011 concerning Guillain-Barre syndrome in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

 

6.             The contents of this Instrument are in similar terms as the revoked Instrument.  Comparing this Instrument and the revoked Instrument, the differences include:

 

  • revising the definition of 'Guillain-Barre syndrome' in clause 3;
  • revising factor 6(a) concerning 'an infection from the specified list';
  • revising factor 6(b) concerning 'human immunodeficiency virus';
  • revising factor 6(d) concerning 'a specified vaccine';
  • new factor 6(e) concerning 'herpes zoster infection';
  • new factor 6(f) concerning 'solid organ or bone marrow transplantation';
  • new factor 6(g) concerning 'surgery requiring a general, spinal or epidural anaesthetic';
  • new factor 6(h) concerning 'solid organ or bone marrow malignancy';
  • new definition of 'an infection from the specified list' in clause 9;
  • revising the definitions of 'a specified vaccine', 'ICD-10-AM code' and 'relevant service' in clause 9; and
  • specifying a date of effect for the Instrument in clause 11.

 

7.             Further changes to the format of the Instrument reflect the commencement of the MRCA and clarify that pursuant to subsection 196B(3A) of the VEA, the Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

 

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to Guillain-Barre syndrome in the Government Notices Gazette of 18 May 2011, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  One submission was received for consideration by the Authority during the investigation.

 

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.

 

10.         The determining of this Instrument finalises the investigation in relation to Guillain-Barre syndrome as advertised in the Government Notices Gazette of 18 May 2011.

 

11.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

 

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 59 of 2013

Kind of Injury, Disease or Death: Guillain-Barre syndrome

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have Guillain-Barre syndrome;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting Guillain-Barre syndrome with the circumstances of eligible service rendered by a person, as set out in clause 4 of the Explanatory Notes;
  • replaces Instrument No. 53 of 2005; and
  • reflects developments in the available sound medical-scientific evidence concerning Guillain-Barre syndrome which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members; and
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Repatriation Medical Authority Instrument No. 59 of 2013, enacted under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, was introduced to address the medical-scientific evidence indicating a relationship between Guillain-Barre syndrome and particular kinds of military service. The Authority revoked the previous Instrument No. 53 of 2005 and determined a new Statement of Principles concerning Guillain-Barre syndrome, reflecting the sound medical-scientific evidence available. This legislative instrument facilitates the assessment and determination of claims for compensation by outlining the minimum factors that must exist to connect Guillain-Barre syndrome or death from Guillain-Barre syndrome with the circumstances of eligible military service. The Authority's investigation, which commenced on 1 July 2004, involved an examination of the available evidence and resulted in the determination of this new instrument, which replaces the previous one and incorporates revisions and new factors based on recent medical-scientific developments. This instrument is compatible with human rights, promoting various rights, including social security, an adequate standard of living, and the highest attainable standard of physical and mental health.

Scope and Application

The Repatriation Medical Authority Instrument No. 59 of 2013, under subsection 196B(8) of the Veterans' Entitlements Act 1986, pertains to the revision of previously determined statements of principles concerning Guillain-Barre syndrome. This instrument applies to individuals who have served in operational, peacekeeping, hazardous, British nuclear test defence, warlike, or non-warlike service and who are seeking to claim medical treatment and compensation for Guillain-Barre syndrome under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. The instrument is effective for claims concerning service injuries, diseases, or deaths that occurred on or after 1 July 2004. It outlines the factors that must exist to establish a connection between the service and the syndrome, reflecting advancements in medical-scientific evidence. The instrument is subject to review by the Veterans' Review Board and the Administrative Appeals Tribunal and is compatible with human rights as it does not derogate from and promotes the rights of veterans and their dependents to social security and health care. The Authority may extend or restrict the application of this instrument through subordinate instruments.

Key Provisions

The key provisions of this legislation revolve around the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). Under section 196B(8) of the VEA, the Repatriation Medical Authority has revoked Instrument No. 53 of 2005 concerning Guillain-Barre syndrome and has issued a new Statement of Principles, Instrument No. 59 of 2013. This new instrument specifies the circumstances in which medical treatment and compensation can be extended to eligible persons who have Guillain-Barre syndrome and outlines the factors that must exist to connect the syndrome with particular types of service rendered by a person. The Statement of Principles includes the types of service that may be considered in relation to Guillain-Barre syndrome, such as operational service, peacekeeping service, hazardous service, and others. The legislation also incorporates changes to the definitions and factors considered in determining the connection between Guillain-Barre syndrome and service, reflecting the latest medical-scientific evidence. The obligations imposed by the Act on the parties primarily concern the Repatriation Medical Authority, which must assess claims for compensation under the VEA and MRCA. The Authority must ensure that the Statement of Principles is aligned with the current sound medical-scientific evidence and is compatible with human rights. It must also facilitate the review of decisions by the Veterans' Review Board and the Administrative Appeals Tribunal. Claimants must provide evidence that meets the criteria outlined in the Statement of Principles to be eligible for compensation. Additionally, the Repatriation Commission, responsible for assessing claims, must apply the new Statement of Principles in their evaluations. There are no specific offences, penalties, or consequences outlined in the explanatory notes for breaching the provisions of this legislation. However, failure to comply with the requirements of the VEA and MRCA, including providing false information or documentation, may lead to civil or criminal consequences. Under the VEA, penalties for providing false or misleading information can include fines, imprisonment, or both, depending on the severity of the offence. The MRCA also provides for penalties for similar breaches, including fines and imprisonment. The maximum penalties are not specified in the explanatory notes but would typically be determined by the relevant courts based on the nature and extent of the breach.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Instrument
Concepts
Definitions & Interpretation
Regulatory Standards
Compliance Obligations
Rights & Protections

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.